Document is current
Any future updates will be listed below
-
Authors
Dy, Christopher J. http://orcid.org/0000-0003-1422-2483
Pesko, Michael F.
Keller, Matthew
Sepper, Elizabeth
Olsen, Margaret A.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR000448, Sub award KL2 TR000450, UL1 TR000448)
Agency for Healthcare Research and Quality (R24 HS19455)
National Cancer Institute (KM1CA156708)
-
License Information
Text and Data Mining valid from 2019-01-03
Version of Record valid from 2019-01-03
-
More Information
Article History
Received: 11 July 2018
Accepted: 8 November 2018
First Online: 3 January 2019
Compliance with Ethical Standards
:
: Michael F. Pesko, PhD, and Elizabeth Sepper, JD, declare that they have no conflicts of interest. Christopher J. Dy, MD, MPH, reports support from grant number UL1 TR000448, Sub award KL2 TR000450, from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS), and from the NIH Roadmap for Medical Research, during the conduct of the study. Margaret A. Olsen, PhD, MPH, reports grants and personal fees from Pfizer and grants from Sanofi Pasteur, outside the submitted work. Matthew Keller, MS, and Margaret A. Olsen, PhD, MPH, report partial support from the Center for Administrative Data Research at the Washington University Institute of Clinical and Translational Sciences, grant number UL1 TR000448 from NCATS, grant number R24 HS19455 from the Agency for Healthcare Research and Quality (AHRQ), and grant number KM1CA156708 from the National Cancer Institute (NCI) at the NIH.
: N/A
: N/A
: Disclosure forms provided by the authors are available with the online version of this article.
